About this study
The BE SURE study is testing whether an investigational medication called bimekizumab is safe and effective for moderate to severe chronic plaque psoriasis.
If you are:
- 18 years of age or older
- Have been diagnosed with moderate to severe chronic plaque psoriasis, and
- Have had the condition for at least six months, you may be able to take part*.
*Other medical criteria must be met before you can join the study; these will be assessed by the study team.